OPTIFINE, created in 2000 (Switzerland), from 30 sister brands and 4472 competing brands. OPTIFINE is owned by YPSOMED N, listed on the stock exchange of Zurich Its International Securities Identification Number (ISIN) is CH0019396990. OPTIFINE belongs to the Medical Devices & Instruments business sector.

Share price and profitability of the share YPSOMED N (OPTIFINE)

Buy YPSOMED N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 337.50

Portfolio valuation
YPSOMED N (OPTIFINE) over 5 years* CHF 859.85

Stock market history YPSOMED N (OPTIFINE)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
YPSOMED N

See more brands of YPSOMED N

Rival brands
OPTIFINE

CooperSurgical
CooperSurgical
CooperVision
CooperVision
POLYPLUS
POLYPLUS
ESSILORLUXOTTICA
ESSILORLUXOTTICA
AERIE PHARMACEUTICALS
AERIE PHARMACEUTICALS
BIODISCOVERY
BIODISCOVERY
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking